NRC · NASDAQ
NRC Health (NRC) Stock Price & Fundamentals
NRC Health (NRC) closed at $799.69 on Oct 9, 2026, down 0.55% from the previous close of $804.09.
Share price, past year
1Y +18.02%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $799.69 |
| Sep 30, 2026 | $791.67 |
| Aug 31, 2026 | $755.33 |
| Jul 31, 2026 | $737.19 |
| Jun 30, 2026 | $711.15 |
| May 29, 2026 | $696.90 |
| Apr 30, 2026 | $709.12 |
| Mar 31, 2026 | $683.72 |
| Feb 27, 2026 | $715.42 |
| Jan 30, 2026 | $710.65 |
| Dec 31, 2025 | $697.85 |
| Nov 28, 2025 | $719.42 |
| Oct 31, 2025 | $728.51 |
Key statistics
- Market cap
- $17.70B
- P/E (TTM)
- 16.1
- EPS (TTM)
- $49.75
- Revenue (TTM)
- $140.00M
- Net income (TTM)
- —
- Shares outstanding
- 22.1M
- Dividend yield
- 0.08%
- 52-week range
- $675.65 – $812.14
NRC Health's market cap is $17.70B, based on a share price of $799.69 and 22.1M shares outstanding as of Jun 30, 2026.
Financials
NRC Health reported revenue of $137.39M for fiscal 2025, down 3.96% from fiscal 2024.
NRC Health earned net income of $30.05M in fiscal 2018, a net margin of 25.1%.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $137.39M | −4.0% | — | — | $50.00 | $15.74M |
| FY2024ended Dec 31, 2024 | $143.06M | −3.7% | — | — | $1.04 | $19.18M |
| FY2023ended Dec 31, 2023 | $148.58M | −2.0% | — | — | $1.25 | $22.33M |
| FY2022ended Dec 31, 2022 | $151.57M | +2.4% | — | — | $1.27 | $26.43M |
| FY2021ended Dec 31, 2021 | $147.95M | +11.0% | — | — | $1.46 | $40.83M |
| FY2020ended Dec 31, 2020 | $133.28M | +4.1% | — | — | $1.45 | $36.65M |
| FY2019ended Dec 31, 2019 | $127.98M | +6.9% | — | — | $1.26 | $36.26M |
| FY2018ended Dec 31, 2018 | $119.69M | +1.8% | $30.05M | 25.1% | — | $33.88M |
| FY2017ended Dec 31, 2017 | $117.56M | +7.5% | $22.94M | 19.5% | — | $23.52M |
| FY2016ended Dec 31, 2016 | $109.38M | — | $20.52M | 18.8% | — | $22.87M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $35.39M | −$3.28M | −$0.15 |
| Q1 FY2026ended Mar 31, 2026 | $34.80M | $3.22M | $0.14 |
| Q4 FY2025ended Dec 31, 2025 | $35.19M | — | $49.58 |
| Q3 FY2025ended Sep 30, 2025 | $34.61M | — | $0.18 |
| Q2 FY2025ended Jun 30, 2025 | $34.04M | −$106.00K | −$0.01 |
| Q1 FY2025ended Mar 31, 2025 | $33.55M | $5.79M | $0.25 |
| Q4 FY2024ended Dec 31, 2024 | $36.91M | — | $0.27 |
| Q3 FY2024ended Sep 30, 2024 | $35.82M | — | $0.24 |
Company profile
- Name
- NRC Health
- Ticker
- NRC
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Commercial Physical & Biological Research
- Headquarters
- 1245 Q Street, Lincoln, NE 68508
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000070487
Recent SEC filings
- Aug 11, 2026
- Aug 4, 2026
- Jul 28, 2026
- Jun 29, 2026
- May 6, 2026
- Apr 28, 2026
- Apr 28, 2026
- Apr 28, 2026
Frequently asked questions
What is NRC Health's stock price?
NRC Health (NRC) closed at $799.69 on Oct 9, 2026, down 0.55% from the previous close of $804.09.
What is NRC Health's market cap?
NRC Health's market cap is $17.70B, based on a share price of $799.69 and 22.1M shares outstanding as of Jun 30, 2026.
How much revenue does NRC Health make?
NRC Health reported revenue of $137.39M for fiscal 2025, down 3.96% from fiscal 2024.
What is NRC's P/E ratio?
NRC Health's price-to-earnings ratio is 16.1, based on trailing twelve-month diluted EPS of $49.75.
Does NRC Health pay a dividend?
Yes. NRC Health declared $0.60 per share in dividends over the last four quarters, a yield of 0.08%.
Sources and methodology
Fundamentals come from NRC Health's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures